Literature DB >> 31858826

MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3'UTR -12 bp to + 154 bp.

Xue Wu1, Feng-Ling Xu1, Xi Xia1, Bao-Jie Wang1, Jun Yao1.   

Abstract

Background: The abnormal expression Dopamine D1 receptor (DRD1) gives rise to the dysfunction of dopaminergic neurotransmitter and may be associated with the occurrence of schizophrenia. MicroRNAs (miRNAs) can regulate the DRD1 expression by binding 3'UTR and be involved in the post-transcriptional regulation.
Methods: We first constructed the pmirGLO-recombined vectors of series of DRD1 gene 3'UTR-truncated fragments and performed the luciferase receptor assay to screen the underlying 3'UTR sequence targeted by miRNAs. Then, we predicted the potential miRNAs binding the target sequence and confirmed their effects using luciferase receptor assay after transfection of the miRNA mimics/inhibitors. We also examined the effects of the miRNA on the endogenous DRD1 expression.
Results: We found that the DRD1 3'UTR ranging from -12 to +1135 bp was essential for the post-transcriptional regulation of miRNAs. The deletion of -12 to +154 bp fragment significantly increased the luciferase expression but not the mRNA expression. The miRNA-15a, miRNA-15b and miRNA 16 affected DRD1 expression in HEK293, U87, SK-N-SH and SH-SY5Y cell lines.
Conclusion: The miRNA-15a, miRNA-15b and miRNA-16 inhibit the human dopamine D1 receptor expression by targeting 3'UTR -12 to +154 bp.HighlightsDRD1 3'UTR ranging from -12 to +1135 bp was essential for the post-transcriptional regulation of miRNAs.The deletion of -12 to +154 bp fragment significantly increased the luciferase expression but not the mRNA expression.The miRNA-15a, miRNA-15b and miRNA 16 affected DRD1 expression in different cell lines, respectively.

Entities:  

Keywords:  DRD1; dopamine; microRNA; regulation; schizophrenia

Mesh:

Substances:

Year:  2020        PMID: 31858826     DOI: 10.1080/21691401.2019.1703729

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  4 in total

Review 1.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

2.  MiR-4763-3p targeting RASD2as a Potential Biomarker and Therapeutic Target for Schizophrenia.

Authors:  Jiao Wang; Wenxin Qi; Hongwei Shi; Lin Huang; Fujiang Ning; Fushuai Wang; Kai Wang; Haotian Bai; Hao Wu; Junyi Zhuang; Huanle Hong; Haicong Zhou; Hu Feng; Yinping Zhou; Naijun Dong; Li Liu; Yanyan Kong; Jiang Xie; Robert Chunhua Zhao
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

Review 3.  Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease.

Authors:  Emilia Pascale; Giuseppina Divisato; Renata Palladino; Margherita Auriemma; Edward Faustine Ngalya; Massimiliano Caiazzo
Journal:  Biomolecules       Date:  2020-09-03

4.  The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.

Authors:  Lingling Jiang; Xuexin Wang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.